{"id":22469,"date":"2023-03-31T10:08:35","date_gmt":"2023-03-31T17:08:35","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22469"},"modified":"2024-01-29T18:10:20","modified_gmt":"2024-01-29T18:10:20","slug":"tysabri-natalizumab","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/","title":{"rendered":"Tysabri: \u00bfEs el tratamiento adecuado para usted?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Tysabri, tambi\u00e9n conocido por su nombre gen\u00e9rico \u201cnatalizumab\u201d, es un medicamento recetado indicado para el tratamiento de <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/living-with-crohns-disease-what-you-should-know\/\">enfermedad de Crohn<\/a> y formas recurrentes de esclerosis m\u00faltiple (EM) en adultos.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-a29023d3b9ffcf9046963cc4d913042c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">En 2004, la FDA autoriz\u00f3 su uso como el primer anticuerpo monoclonal para el tratamiento de la esclerosis m\u00faltiple (EM) recurrente-remitente activa (una enfermedad debilitante del cerebro y la m\u00e9dula espinal). Tysabri es un medicamento que pertenece a la clase de anticuerpos monoclonales.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri viene en forma l\u00edquida y est\u00e1 disponible a trav\u00e9s de un programa restringido especial llamado <\/span><a href=\"https:\/\/www.touchprogram.com\/TTP\/\"><span style=\"font-weight: 400;\">TOCAR<\/span><\/a><span style=\"font-weight: 400;\">Este medicamento s\u00f3lo puede obtenerse con receta m\u00e9dica.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#What_Is_Tysabri_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza Tysabri?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#How_Does_Tysabri_Work\" >\u00bfC\u00f3mo funciona Tysabri?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Tysabri_Dosage_Form_and_Strength\" >Forma farmac\u00e9utica y concentraci\u00f3n de Tysabri<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Tysabri_dilution_procedure\" >Procedimiento de diluci\u00f3n de Tysabri:<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Tysabri_Dosing_Information\" >Informaci\u00f3n de dosificaci\u00f3n de Tysabri<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#How_Is_Tysabri_Given\" >\u00bfC\u00f3mo se administra Tysabri?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Is_Tysabri_a_Form_of_Chemotherapy\" >\u00bfEs Tysabri una forma de quimioterapia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Interaction_With_Other_Drugs\" >Interacci\u00f3n con otros medicamentos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Possible_Side_Effects_of_Tysabri\" >Posibles efectos secundarios de Tysabri<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Precautions\" >Precauciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/#Cost\" >Costo&nbsp;<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Tysabri_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza Tysabri?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri se utiliza como monoterapia (no en combinaci\u00f3n con otras terapias modificadoras de la enfermedad) para tratar las siguientes afecciones:<\/span><\/p>\n\n\n\n<p><b>Formas recurrentes de esclerosis m\u00faltiple (EM)<\/b><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La esclerosis m\u00faltiple es una enfermedad neurol\u00f3gica autoinmune cr\u00f3nica y debilitante en la que el sistema inmunitario del paciente ataca por error la vaina de mielina (una capa protectora) de las c\u00e9lulas nerviosas del cerebro y la m\u00e9dula espinal. Este ataque inmunitario provoca inflamaci\u00f3n debido al da\u00f1o nervioso, lo que provoca discapacidad motora, visi\u00f3n borrosa, dificultad para hablar, dolor cr\u00f3nico y fatiga.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los s\u00edntomas de la esclerosis m\u00faltiple (EM) suelen fluctuar en personas con EM recurrente. Los pacientes con EM experimentan nuevas lesiones o brotes de los s\u00edntomas existentes durante unos d\u00edas o semanas, seguidos de las fases de recuperaci\u00f3n, donde los s\u00edntomas pueden aliviarse o desaparecer temporalmente.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri se recomienda generalmente como monoterapia para tratar a personas con formas recurrentes de esclerosis m\u00faltiple con el fin de prevenir la aparici\u00f3n de deterioro f\u00edsico y disminuir la frecuencia de las exacerbaciones cl\u00ednicas. A los pacientes que no han respondido bien a un medicamento alternativo para la EM o que no toleran bien este medicamento, generalmente se les recomienda usar Tysabri.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri est\u00e1 dise\u00f1ado para ayudar a las personas con formas recurrentes de EM a experimentar menos brotes y posponer o evitar la discapacidad f\u00edsica.<\/span><\/p>\n\n\n\n<p><b>Enfermedad de Crohn (EC)<\/b><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La enfermedad de Crohn, un trastorno inflamatorio, causa inflamaci\u00f3n en el tracto gastrointestinal o en cualquiera de sus segmentos, con mayor frecuencia en el intestino delgado o grueso. Aunque se desconoce la etiolog\u00eda precisa de la EC, se cree que se debe a una reacci\u00f3n autoinmune, en la que el sistema inmunitario ataca las c\u00e9lulas sanas.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los s\u00edntomas de la EC son heces con sangre, diarrea, fiebre, fatiga, p\u00e9rdida de peso, calambres abdominales y movimientos intestinales frecuentes.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri generalmente se recomienda para pacientes con EC de moderada a grave y ha demostrado una respuesta inadecuada a las terapias para la EC, como los bloqueadores del factor de necrosis tumoral (TFN).&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri se utiliza para disminuir los signos y s\u00edntomas en pacientes con EC.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Tysabri_Work\"><\/span>\u00bfC\u00f3mo funciona Tysabri?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri contiene un componente activo, \u201c<\/span><span style=\"font-weight: 400;\">natalizumab\u201d, un tipo de <a href=\"https:\/\/my.clevelandclinic.org\/health\/treatments\/22246-monoclonal-antibodies\">anticuerpo monoclonal<\/a> que reconoce y se une a las prote\u00ednas receptoras espec\u00edficas llamadas integrinas (<\/span><span style=\"font-weight: 400;\">con subunidades \u03b14\u03b21 y \u03b14\u03b27) en los gl\u00f3bulos blancos (WBC).&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Nuestro sistema inmunitario normalmente est\u00e1 compuesto por gl\u00f3bulos blancos (GB), encargados de eliminar las c\u00e9lulas extra\u00f1as. Por el contrario, estas c\u00e9lulas da\u00f1an las c\u00e9lulas sanas en la EM y la EC, lo que provoca inflamaci\u00f3n.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">En MS, n<\/span><span style=\"font-weight: 400;\">El atalizumab (el f\u00e1rmaco activo) se une a<\/span> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6629825\/\"><b>\u03b14\u03b21 <\/b><\/a><span style=\"font-weight: 400;\">Las integrinas, prote\u00ednas de superficie de los gl\u00f3bulos blancos, impiden que los gl\u00f3bulos blancos crucen la barrera hematoencef\u00e1lica (una barrera que protege el cerebro y la m\u00e9dula espinal de posibles toxinas y c\u00e9lulas inmunitarias hiperactivas). Como resultado de...<\/span><span style=\"font-weight: 400;\">La uni\u00f3n del atalizumab a la <\/span><span style=\"font-weight: 400;\">Integrinas \u03b14\u03b21, reducen el da\u00f1o nervioso y la inflamaci\u00f3n en los tejidos cerebrales y espinales.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">En el caso del CD, la n<\/span><span style=\"font-weight: 400;\">El atalizumab se une a <\/span><b>\u03b14\u03b27<\/b><span style=\"font-weight: 400;\"> Las integrinas son prote\u00ednas de superficie de los gl\u00f3bulos blancos y evitan que estos provoquen inflamaci\u00f3n en el tracto gastrointestinal.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri ayuda a reducir los s\u00edntomas de la esclerosis m\u00faltiple y la enfermedad de Crohn.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-04809731b5a1af8ae14a47bae39b9bd7\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n del tratamiento\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tObtenga autorizaci\u00f3n previa para Tysabri\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tysabri_Dosage_Form_and_Strength\"><\/span>Forma farmac\u00e9utica y concentraci\u00f3n de Tysabri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri se presenta en una soluci\u00f3n l\u00edquida inyectable est\u00e9ril y concentrada en un vial de un solo uso. Tysabri solo est\u00e1 disponible en una concentraci\u00f3n: 300 mg\/15 ml (20 mg\/ml).&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Dado que Tysabri viene en forma concentrada, debe diluirse antes de su uso.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tysabri_dilution_procedure\"><\/span><span style=\"font-weight: 400;\">Procedimiento de diluci\u00f3n de Tysabri:<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Retire los 15 ml de concentrado de Tysabri (300 mg) del vial con una jeringa est\u00e9ril e iny\u00e9ctelo en 100 ml de inyecci\u00f3n de cloruro de sodio 0,9%.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mezcle el contenido de la inyecci\u00f3n invirti\u00e9ndolo suavemente.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">La dosis final ser\u00e1 de 2,6 mg\/ml.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Utilice la diluci\u00f3n de Tysabri dentro de las 8 horas.<\/span><\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tysabri_Dosing_Information\"><\/span>Informaci\u00f3n de dosificaci\u00f3n de Tysabri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Para pacientes con EM y EC, la dosis recomendada de Tysabri es una infusi\u00f3n intravenosa de 300 mg administrada durante una hora, una vez cada cuatro semanas (una dosis por mes).<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Las infusiones de Tysabri deben suspenderse si un paciente con EC no ve resultados terap\u00e9uticos durante las primeras 12 semanas de terapia.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Tysabri_Given\"><\/span>\u00bfC\u00f3mo se administra Tysabri?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri solo se administra por v\u00eda intravenosa (a trav\u00e9s de las venas) durante una hora una vez cada cuatro semanas. Se debe vigilar a los pacientes durante o despu\u00e9s de las infusiones intravenosas de una hora, ya que la infusi\u00f3n puede provocar reacciones al\u00e9rgicas.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Si ha perdido su cita de infusi\u00f3n, consulte a su proveedor de atenci\u00f3n m\u00e9dica inmediatamente para recibir la dosis.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Tysabri_a_Form_of_Chemotherapy\"><\/span>\u00bfEs Tysabri una forma de quimioterapia?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">No, Tysabri no es un medicamento de quimioterapia, sino un inmunosupresor que funciona de forma diferente a los medicamentos de quimioterapia. A diferencia de la quimioterapia, que detiene el crecimiento del c\u00e1ncer, Tysabri, como inmunosupresor, inhibe el sistema inmunitario.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Esta supresi\u00f3n ayuda a controlar los s\u00edntomas de la esclerosis m\u00faltiple y la enfermedad de Crohn. Sin embargo, por otro lado, la inmunosupresi\u00f3n tambi\u00e9n aumenta el riesgo de infecci\u00f3n.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Interaction_With_Other_Drugs\"><\/span>Interacci\u00f3n con otros medicamentos<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri <\/span><span style=\"font-weight: 400;\">No debe utilizarse en combinaci\u00f3n con otros f\u00e1rmacos inmunosupresores y bloqueadores del TNF, ya que puede aumentar el riesgo de desarrollar <\/span><span style=\"font-weight: 400;\">leucoencefalopat\u00eda multifocal progresiva (LMP)<\/span><span style=\"font-weight: 400;\">.&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Inmunosupresores:<\/b><span style=\"font-weight: 400;\"> Azatioprina, ciclosporina y metotrexato.<\/span><\/li>\n\n\n\n<li><b>Bloqueadores del TNF:&nbsp;<\/b><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-inflectra-infliximab-dyyb\/\">Infliximab<\/a>, adalimumab y golimumab.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Possible_Side_Effects_of_Tysabri\"><\/span>Posibles efectos secundarios de Tysabri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects.jpg\" alt=\"Woman suffering from headache after taking Tysabri\" class=\"wp-image-22472\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/tysabri-side-effects-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Los efectos secundarios comunes de Tysabri que un paciente puede experimentar durante o despu\u00e9s de la infusi\u00f3n intravenosa incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">dolores de cabeza<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mareos y n\u00e1useas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatiga<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor articular<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Nasofaringitis (inflamaci\u00f3n de la nariz y la garganta)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecciones leves como infecciones del tracto urinario, vaginales, respiratorias y estomacales.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Reacci\u00f3n al\u00e9rgica leve<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrea<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Tysabri tambi\u00e9n presenta efectos secundarios graves y potencialmente mortales que requieren atenci\u00f3n m\u00e9dica inmediata. Algunos de los efectos secundarios graves reportados en pacientes incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.healthline.com\/health\/pml-virus\"><span style=\"font-weight: 400;\">Leucoencefalopat\u00eda multifocal progresiva (LMP)<\/span><\/a><span style=\"font-weight: 400;\">, una rara infecci\u00f3n cerebral que causa discapacidad grave o incluso la muerte&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecci\u00f3n por herpes que afecta el cerebro o los ojos.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">da\u00f1o hep\u00e1tico<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Recuentos bajos de plaquetas y gl\u00f3bulos rojos<\/span><\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-ca85547f28b8a08f8ba5096f95a5d9d5\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precautions\"><\/span>Precauciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Antes de recibir infusiones de Tysabri IV, debe consultar a su proveedor de atenci\u00f3n m\u00e9dica si:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Son menores de 18 a\u00f1os, ya que no se sabe si Tysabri es seguro y funciona en pacientes menores de edad.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Est\u00e1 embarazada o planea quedar embarazada, ya que este medicamento puede da\u00f1ar a su beb\u00e9 nonato y causar un bajo conteo de plaquetas y gl\u00f3bulos rojos (anemia) en los reci\u00e9n nacidos.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Est\u00e1 amamantando o planea hacerlo. Dado que los datos sobre la secreci\u00f3n de Tysabri en la leche materna son limitados, se recomienda evitar la infusi\u00f3n de Tysabri en estos casos.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Est\u00e1 tomando otros inmunosupresores o corticosteroides, ya que el uso de Tysabri en combinaci\u00f3n con bloqueadores del TNF o medicamentos inmunosupresores aumenta el riesgo de infecci\u00f3n por LMP.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene o ha tenido otras afecciones m\u00e9dicas que debilitan su sistema inmunol\u00f3gico, como VIH, SIDA, leucemia y trasplantes de \u00f3rganos.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene alergia a los componentes de Tysabri.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>Costo<span style=\"font-weight: 400;\">&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Se estima que un vial monodosis de 300 mg costar\u00e1 aproximadamente $8,282. El precio de Tysabri puede variar seg\u00fan la farmacia que visite y su seguro m\u00e9dico.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Tysabri, tambi\u00e9n conocido por su nombre gen\u00e9rico &quot;natalizumab&quot;, es un medicamento de prescripci\u00f3n indicado para el tratamiento de la enfermedad de Crohn y las formas recurrentes de esclerosis m\u00faltiple (EM) en adultos. En 2004, la FDA autoriz\u00f3 su uso como el primer anticuerpo monoclonal para el tratamiento de la EM recurrente-remitente activa (una enfermedad debilitante del cerebro y la m\u00e9dula espinal).<\/p>","protected":false},"author":16,"featured_media":22471,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[21],"class_list":["post-22469","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-martina-mikail"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tysabri: Is It the Right Treatment for You?<\/title>\n<meta name=\"description\" content=\"Learn about Tysabri (natalizumab) and how it works. Topics covered include dosage, interactions, side effects, precautions, cost and more.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tysabri: Is It the Right Treatment for You?\" \/>\n<meta property=\"og:description\" content=\"Learn about Tysabri (natalizumab) and how it works. Topics covered include dosage, interactions, side effects, precautions, cost and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-31T17:08:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-29T18:10:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Martina Mikail, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Martina Mikail, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/\"},\"author\":{\"name\":\"Dr. Martina Mikail, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/1a08790136f47e0a1978629cdfeca933\"},\"headline\":\"Tysabri: Is It the Right Treatment for You?\",\"datePublished\":\"2023-03-31T17:08:35+00:00\",\"dateModified\":\"2024-01-29T18:10:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/\"},\"wordCount\":1160,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/damaged-neuron.jpg\",\"keywords\":[\"Dr. Martina Mikail\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/\",\"name\":\"Tysabri: Is It the Right Treatment for You?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/damaged-neuron.jpg\",\"datePublished\":\"2023-03-31T17:08:35+00:00\",\"dateModified\":\"2024-01-29T18:10:20+00:00\",\"description\":\"Learn about Tysabri (natalizumab) and how it works. Topics covered include dosage, interactions, side effects, precautions, cost and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/damaged-neuron.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/damaged-neuron.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Demyelination of a neuron in MS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/tysabri-natalizumab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tysabri: Is It the Right Treatment for You?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/1a08790136f47e0a1978629cdfeca933\",\"name\":\"Dr. Martina Mikail, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g\",\"caption\":\"Dr. Martina Mikail, PharmD\"},\"description\":\"Dr. Martina Mikail, PharmD was born in Egypt and raised in Pennsylvania and California. She graduated from Marshall B. Ketchum University in May 2022. Dr. Mikail is a recipent of the USPS Leadership Award and the CSHP Leadership Award, and is an active member of CSHP, ASHP, and APhA. The most rewarding part of her job is educating patients and counseling them on medications. In her free time, she likes to cook, spend time with family, and read.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/martina-mikail\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tysabri: \u00bfEs el tratamiento adecuado para usted?","description":"Inf\u00f3rmese sobre Tysabri (natalizumab) y c\u00f3mo funciona. Se tratan temas como la dosis, las interacciones, los efectos secundarios, las precauciones, el costo y m\u00e1s.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_MX","og_type":"article","og_title":"Tysabri: Is It the Right Treatment for You?","og_description":"Learn about Tysabri (natalizumab) and how it works. Topics covered include dosage, interactions, side effects, precautions, cost and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-03-31T17:08:35+00:00","article_modified_time":"2024-01-29T18:10:20+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg","type":"image\/jpeg"}],"author":"Dr. Martina Mikail, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Martina Mikail, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/"},"author":{"name":"Dr. Martina Mikail, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/1a08790136f47e0a1978629cdfeca933"},"headline":"Tysabri: Is It the Right Treatment for You?","datePublished":"2023-03-31T17:08:35+00:00","dateModified":"2024-01-29T18:10:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/"},"wordCount":1160,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg","keywords":["Dr. Martina Mikail"],"articleSection":["Other Health Conditions"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/","url":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/","name":"Tysabri: \u00bfEs el tratamiento adecuado para usted?","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg","datePublished":"2023-03-31T17:08:35+00:00","dateModified":"2024-01-29T18:10:20+00:00","description":"Inf\u00f3rmese sobre Tysabri (natalizumab) y c\u00f3mo funciona. Se tratan temas como la dosis, las interacciones, los efectos secundarios, las precauciones, el costo y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg","width":1280,"height":853,"caption":"Demyelination of a neuron in MS"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/tysabri-natalizumab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Tysabri: Is It the Right Treatment for You?"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/1a08790136f47e0a1978629cdfeca933","name":"Dra. Martina Mikail, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g","caption":"Dr. Martina Mikail, PharmD"},"description":"La Dra. Martina Mikail, doctora en farmacia, naci\u00f3 en Egipto y creci\u00f3 en Pensilvania y California. Se gradu\u00f3 de la Universidad Marshall B. Ketchum en mayo de 2022. La Dra. Mikail ha recibido los Premios de Liderazgo del Servicio Postal de los Estados Unidos (USPS) y del CSHP, y es miembro activo de CSHP, ASHP y APhA. Lo m\u00e1s gratificante de su trabajo es educar a los pacientes y asesorarlos sobre sus medicamentos. En su tiempo libre, le gusta cocinar, pasar tiempo con su familia y leer.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/martina-mikail\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Martina Mikail, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/martina-mikail\/"},"uagb_comment_info":0,"uagb_excerpt":"Tysabri, also known by its generic name \"natalizumab,\" is a prescription medication indicated for the treatment of Crohn's disease and relapsing forms of multiple sclerosis (MS) in adults.\u00a0In 2004, the FDA authorized its use as the first monoclonal antibody for the treatment of active relapsing-remitting MS (a debilitating disease of the brain and spinal cord).","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/03\/damaged-neuron.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Martina Mikail, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/martina-mikail\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"Tysabri, also known by its generic name \"natalizumab,\" is a prescription medication indicated for the treatment of Crohn's disease and relapsing forms of multiple sclerosis (MS) in adults.\u00a0In 2004, the FDA authorized its use as the first monoclonal antibody for the treatment of active relapsing-remitting MS (a debilitating disease of the brain and spinal cord).","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=22469"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22469\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/22471"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=22469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=22469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=22469"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}